Acute Bronchitis Clinical Trial
Official title:
Management of Acute Bronchitis in Switzerland With Pelargonium Sidoides Extract EPs®7630 Versus Usual Care - a Pragmatic, Open-label, Randomised Controlled Trial
The aim of our study is to conduct a pragmatic RCT meeting all required standards to evaluate the effectiveness of Pelargonium sidoides extract, EPs® 7630, in the management of acute bronchitis with or without COVID-19 in PCP practices and walk-in clinics in French-speaking Switzerland. The RCT will be preceded by a pilot phase to ensure its feasibility.
The goal of this clinical trial is to evaluate the effectiveness of Pelargonium sidoides extract EPs® 7630, also known under the brand name Kaloba®, in the management of acute bronchitis. The main questions it aims to answer are: - Is Pelargonium sidoides extract EPs® 7630 effective to reduce the severity and the duration of symptoms related to acute bronchitis ? - Does Pelargonium sidoides extract EPs® 7630 allow to reduce the prescription of antibiotics? Participants will be randomize 1:1 either in the control group (usual care) or in the intervention group (Pelargonium sidoides extract EPs® 7630). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03711292 -
Using Behavioral Science to Reduce Inappropriate Antibiotic Use in Acute Care Settings
|
N/A | |
Not yet recruiting |
NCT03517215 -
The Development and Testing of a Scaling Strategy for a Community-Based Primary Care Antimicrobial Stewardship Program
|
N/A | |
Completed |
NCT01420445 -
Safety/Tolerability and Efficacy of YHD001 in Patients With Acute and Chronic Bronchitis
|
Phase 2 | |
Completed |
NCT00360464 -
A Trial Of Azithromycin SR For The Treatment Of Acute Bronchitis And Secondary Infection Of Chronic Respiratory Diseases
|
Phase 3 | |
Completed |
NCT05344638 -
A Clinical Trial to Evaluate the Safety and Efficacy of "AG1904" in Acute Bronchitis
|
Phase 3 | |
Completed |
NCT06457269 -
Evaluating the Potential of Large Language Models for Respiratory Disease Consultations
|
N/A | |
Completed |
NCT04239521 -
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
|
||
Recruiting |
NCT03827590 -
Clinical Trials to Assess the Efficacy and Safety of HLIM
|
Phase 3 | |
Completed |
NCT02792946 -
Compare the Efficacy and Safety of Surfolase CR Tablet With Surfolase Capsule in Patients With Acute Bronchitis
|
Phase 3 | |
Completed |
NCT01875757 -
Effect of Supplementation With Vitamin D on the Acute Bronchitis Prevention During the First Year of Life
|
Phase 3 | |
Recruiting |
NCT04252963 -
Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase)
|
Phase 4 | |
Recruiting |
NCT06411925 -
The Efficacy and Safety of Atock Dry Syrup With Acute Bronchitis Patients
|
Phase 4 | |
Completed |
NCT01416480 -
Clinical Trial to Evaluate the Safety and Efficacy of "Theobromine Capsule" as an Antitussive in Acute Cougher
|
Phase 3 | |
Completed |
NCT03309800 -
A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Placebo in Acute Bronchitis Patients
|
Phase 2 | |
Completed |
NCT02250027 -
A Multicenter, Randomized, Double-blind, Parallel Group Study to Determine the Optimal Dose of HL301 After 7 Days Oral Administration in Acute Bronchitis or Acute Exacerbations of Chronic Bronchitis Patients (HL301: Mixed Extract of Rehmannia Glutinosa, Schisandra and so on)
|
Phase 2 | |
Not yet recruiting |
NCT03310385 -
Efficacy and Safety of GHX02 in the Treatment of Acute Bronchitis
|
Phase 2 | |
Completed |
NCT03654196 -
A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Umkamin Tab in Acute Bronchitis Patients
|
Phase 3 | |
Completed |
NCT03011515 -
Evaluating a Host-response Based Diagnostic for Distinguishing Between Bacterial and Viral Etiology in Patients With Lower Respiratory Tract Infection (LRTI)
|
||
Completed |
NCT02045394 -
Epidemiology and Diagnosis of Haemoptysis: a Multicenter Study
|
N/A | |
Completed |
NCT01800747 -
Clinical Trial for the Assessment of Delayed Antibiotic Treatment in Pediatric (DAP-Pediatrics)
|
Phase 4 |